AstraZeneca PLC is 185.9x more valuable than COMPASS Pathways plc by market capitalization ($286.27 B vs $1.54 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CMPS | AZN |
|---|---|---|
| Market cap | $1.54 B | $286.27 B |
| US-listed rank | #2313 | #47 |
| Net income (latest FY) | -$269.77M | - |
| SEC filings | 324 | 1,004 |
AstraZeneca PLC is 185.9x more valuable than COMPASS Pathways plc by market capitalization ($286.27 B vs $1.54 B).
Full pages: COMPASS Pathways plc and AstraZeneca PLC, or browse the full rankings.